Thierry Hulot

- Secretary of the Excecutive Management Board
- Strategic Planning
- Company Performance and Balance Score Card
- Cross Business strategic projects

Provide project management resources, support and training to all development project teams to ensure high quality, speed, and consistency
• Provide high qualified Project Managers (25+) to support the
Global Product Teams in charge of developing the R&D
pipeline.
• Establish a Project Management Office (15+) in charge of
developing the appropriate methods, tools and information
systems to support pipeline development.
• Ensure across projects the consolidation of key project
metric (time, cost, quality) analyse deviation. Facilitate the
portfolio review.
• Drive budgeting exercice for R&D development project and
ensure analysis of deviation.
• Develop and deliver training for Global Product Teams.
• Coordinate benchmarking information collection and analysis.
• Member of the Product Development Commitee steering all the
development programs
• Management of an international team of 40+ people

Lead the Early Stage Global Project Team Leaders (GPTLs) – 8 GPTLs
• Provide pro-active management of development projects,
highlighting issues and potential solutions
• Ensure that for each project a cross-functional product
development strategy, is developed and translated into a cross-
functional operational plan.
• Coordinate across projects day-to-day tradeoffs on
priorities / operational decisions to implement operational
plans, report progress/issues
• Generate basis for Project evaluation (risk/value
evaluation, development of alternatives)

Lead the Project Management (PM) Department (15 Project Managers)
• Develop and ensure implementation of Project
Management processes and reporting tools
• Ensures that PM Dpt supports project teams with
appropriate PM process, tools, techniques & expertise.

Coordinator of the Portfolio Steering Committees

Responsible of a new anti diabetic drug co-developped in the US (Phase II) with a Japanese partner.
• Organisation and management of an international team of 30
people, involving pre-clinical, clinical, marketing, regulatory, and
operations representatives.
• Definition of all project strategies (clinical development plan,
marketing plan). Project planning, resources (human, cash flow)
and project value (patient benefit, NPV) management. Research
of partner.
• Management of all matters concerning our relationship with a
Japanese partner

Definition and implementation of the Department strategy from
early drug discovery to Life Cycle Management.Management of
all operational activities.
• Member of the Development Steering committee. Advisor for the
Generic Affiliate Company.
• Constant contributor in International Project Teams involving US
and Japanese partners. Relationships with Health Authorities
(EMEA, FDA; French Agency).
Department of 12 employees (Scientists, Technicians),
Good Laboratory Practice status